Phase II Study of Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non Hodgkin's Lymphoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 May 2017
At a glance
- Drugs Lenalidomide (Primary) ; Rituximab (Primary)
- Indications Follicular lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 16 May 2017 Status changed from recruiting to active, no longer recruiting.
- 19 Jan 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 19 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.